A Combination of the Tryptophan Hydroxylase Inhibitor Telotristat with the mTOR Inhibitor Everolimus as an Effective Strategy Against Neuroendocrine Tumors.
Saved in:
| Title: | A Combination of the Tryptophan Hydroxylase Inhibitor Telotristat with the mTOR Inhibitor Everolimus as an Effective Strategy Against Neuroendocrine Tumors. |
|---|---|
| Authors: | Molina-Cerrillo, Javier1 (AUTHOR) Javier.molinace@gmail.com, Sierra-Ramirez, Arantzazu2 (AUTHOR), López-Aceituno, José L.2 (AUTHOR), Méndez-Pertuz, Marinela3 (AUTHOR), Alonso-Gordoa, Teresa1 (AUTHOR), Linnebacher, Michael4 (AUTHOR), Santoni, Matteo5 (AUTHOR), Fernandez-Marcos, Pablo J.2 (AUTHOR) pablojose.fernandez@imdea.org, Grande, Enrique6 (AUTHOR) egrande@oncomadrid.com |
| Source: | Drugs in R&D. May2026, p1-13. 13p. |
| Database: | Academic Search Ultimate |
| ISSN: | 11745886 |
|---|---|
| DOI: | 10.1007/s40268-026-00544-x |
